Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren’s syndrome, idiopathic inflammatory myositis and systemic lupus erythematosus....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drugs Context
Главные авторы: Erre, Gian Luca, Sebastiani, Marco, Manfredi, Andreina, Gerratana, Elisabetta, Atzeni, Fabiola, Passiu, Giuseppe, Mangoni, Arduino A
Формат: Artigo
Язык:Inglês
Опубликовано: BioExcel Publishing Ltd 2021
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813437/
https://ncbi.nlm.nih.gov/pubmed/33505482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-8-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы